These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3469194)

  • 1. The safety profile of imipenem/cilastatin: worldwide clinical experience based on 3470 patients.
    Calandra GB; Wang C; Aziz M; Brown KR
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():193-202. PubMed ID: 3469194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imipenem/cilastatin therapy of serious infections: a U.S. multicenter noncomparative trial.
    Calandra GB; Hesney M; Brown KR
    Clin Ther; 1985; 7(2):225-38. PubMed ID: 3886144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy, safety and tolerability of intramuscular imipenem/cilastatin in the treatment of mild to moderate infections.
    Garau J; Casagrán A; Sánchez C; Matas E
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():181-3. PubMed ID: 3469192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imipenem/cilastatin: a multicentre international study of its clinical efficacy, safety and potential as empirical therapy.
    Wang C; Pappas F; Cook T
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():185-91. PubMed ID: 3469193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imipenem/cilastatin: the first carbapenem antibiotic.
    Lyon JA
    Drug Intell Clin Pharm; 1985 Dec; 19(12):895-9. PubMed ID: 3910385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of imipenem/cilastatin in patients with severe bacterial infections.
    Reutter FW
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():141-4. PubMed ID: 3469186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imipenem/cilastatin as secondary therapy for infections in cancer patients.
    Bodey GP; Rolston K; Jones P; Alvarez ME; Fainstein V; Steelhammer L
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():161-6. PubMed ID: 3469189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy results and safety profile of imipenem/cilastatin from the clinical research trials.
    Calandra GB; Ricci FM; Wang C; Brown KR
    J Clin Pharmacol; 1988 Feb; 28(2):120-7. PubMed ID: 3283176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of adverse experiences and tolerability in the first 2,516 patients treated with imipenem/cilastatin.
    Calandra GB; Brown KR; Grad LC; Ahonkhai VI; Wang C; Aziz MA
    Am J Med; 1985 Jun; 78(6A):73-8. PubMed ID: 3859218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of high-dose treatment with imipenem-cilastatin in seriously ill patients.
    Zajac BA; Fisher MA; Gibson GA; MacGregor RR
    Antimicrob Agents Chemother; 1985 May; 27(5):745-8. PubMed ID: 3860187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of imipenem/cilastatin: a review of worldwide clinical experience.
    Wang C; Calandra GB; Aziz MA; Brown KR
    Rev Infect Dis; 1985; 7 Suppl 3():S528-36. PubMed ID: 3901217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imipenem/cilastatin for the treatment of infections in hospitalized children.
    Alpert G; Dagan R; Connor E; Campos JM; Bloh AM; Powell KR; Plotkin SA
    Am J Dis Child; 1985 Nov; 139(11):1153-6. PubMed ID: 3904406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe gram-negative infections in neutropenic children cured by imipenem/cilastatin in combination with an aminoglycoside.
    Baruchel A; Hartmann O; Andremont A; Tancrède C
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():167-73. PubMed ID: 3469190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multiclinic randomized study of the comparative efficacy, safety and tolerance of imipenem/cilastatin and moxalactam.
    Calandra GB; Hesney M; Grad C
    Eur J Clin Microbiol; 1984 Oct; 3(5):478-87. PubMed ID: 6389126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of imipenem/cilastatin sodium in gynecological infection].
    Iwaki M; Sato H; Makinoda S; Demise M; Tabata M; Yamaguchi T; Takaoka H; Shinkai N; Okubo H; Sato H
    Jpn J Antibiot; 1986 Jun; 39(6):1509-13. PubMed ID: 3463791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imipenem/cilastatin therapy for serious infections in neonates and infants.
    Nalin DR; Jacobsen CA
    Scand J Infect Dis Suppl; 1987; 52():46-55. PubMed ID: 3331042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imipenem/cilastatin for pediatric infections in hospitalized patients.
    Nalin DR; Hart CB; Shih WJ; Aziz MA
    Scand J Infect Dis Suppl; 1987; 52():56-64. PubMed ID: 3331043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fundamental and clinical studies of imipenem/cilastatin sodium in the field of obstetrics and gynecology].
    Okamura K; Nakakuki M; Yamada K; Ikeno N; Watanabe M; Takahashi K; Muraguchi K; Saito A; Wakisaka T; Murai H
    Jpn J Antibiot; 1986 Jun; 39(6):1526-30. PubMed ID: 3463794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of imipenem/cilastatin against nosocomial infections and multiresistant pathogens.
    Giamarellou H; Sfikakis P; Voutsinas D; Galanakis N; Daikos GK
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():175-9. PubMed ID: 3469191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fundamental and clinical studies of imipenem/cilastatin sodium in the field of obstetrics and gynecology].
    Fujimoto H; Ikeda K; Yamamoto K; Taguchi S; Shirakawa K
    Jpn J Antibiot; 1986 Jun; 39(6):1607-11. PubMed ID: 3463801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.